Enter to win a $100 gift card to Walmart, courtesy of Tolerx

To help relieve some of your diabetes-related expenses this holiday season, diaTribe is excited to offer you the chance to win a $100 Walmart gift card. Simply fill out the form below and please refer your friends.

Entrants selected in our giveaway will win one of five $100 Walmart gift cards, courtesy of Tolerx. The giveaway will be open until February 28, 2010, with winners selected on March 15, 2010, and notified by email.

Tolerx is a Massachusetts-based biopharmaceutical company devoted to the prevention of type 1 diabetes. Otelixizumab, an anti-CD3 monoclonal antibody being developed by Tolerx for the treatment of type 1 diabetes, is currently being researched in late-stage clinical trials (for more on anti-CD3 therapy, see our Learning Curve from diaTribe #15). A partner of the Juvenile Diabetes Research Foundation (JDRF), Tolerx was also highlighted by JDRF President and CEO Dr. Alan Lewis in our diaTribe dialogue this issue. For more on Tolerx’s ongoing trials, see Trial Watch from diaTribe #9 and #12.

If you don’t currently subscribe to diaTribe, we’ll sign you up for our free, independent newsletter about the latest diabetes research and product news. Please rest assured that we’ll keep your information private, in accordance with our privacy policy.